GLP-1 Archives - Medical Conferences

SUMMIT: Tirzepatide reduces cardiovascular events in HFpEF plus obesity

Presented By

Prof. Milton Packer, Baylor University Medical Center, USA

Trial

Phase 3, SUMMIT

Conference

AHA 2024

Type

News article

18 November 2024 12:25

GLORIOUS: GLP-1 agonist did not meet primary endpoint in CABG

Presented By

Dr Sebastian Wiberg, Rigshospitalet, Denmark

Trial

GLORIOUS

Conference

AHA 2024

Type

News article

18 November 2024 12:18

Semaglutide improves outcomes for patients with obesity and HS

Presented By

Dr Daniel Lyons, St Vincent’s University Hospital, Ireland

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 12:14

The unfavourable role of obesity in psoriatic disease

Presented By

Prof. Ulrich Mrowietz, University Medical Center Schleswig-Holstein, Germany

Conference

IFPA 2024

Type

News article

17 July 2024 14:13

Managing obesity and fibromyalgia in psoriatic disease

Presented By

Prof. Philip Mease, University of Washington, USA

Conference

IFPA 2024

Type

News article

17 July 2024 14:08

Promising data for cardiovascular outcomes of bariatric surgery in patients with obesity

Presented By

Dr Soban Maan, West Virginia University, USA

Conference

DDW 2024

Type

Peer-reviewed article

11 July 2024 13:23

Simulated head-to-head comparison of SGLT-2 inhibitors and GLP-1R agonists in type 2 diabetes

Presented By

Dr Uffe Heide-Jørgensen, Aarhus University, Aarhus, Denmark

Conference

ERA 2024

Type

News article

20 June 2024 19:09

FLOW-trial: Semaglutide improves kidney and cardiovascular outcomes in type 2 diabetes and chronic kidney disease

Presented By

Prof. Vlado Perkovic, University of New South Wales, Sydney, Australia

Trial

Phase 3, FLOW

Conference

ERA 2024

Type

News article

20 June 2024 18:19

STEP-HFpEF DM: Semaglutide beneficial in patients with HFpEF and diabetes

Presented By

Prof. Mikhail Kosiborod, Saint Luke's Mid America Heart Institute, MO, USA

Trial

Phase 3, STEP-HFpEF DM

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 13:20

Successful results for semaglutide in the highly anticipated SELECT trial

Presented By

Dr Michael Lincoff, Cleveland Clinic, USA

Trial

Phase 3, SELECT

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 15:37

Liraglutide may improve post-ablation outcomes in obese patients with AF

Presented By

Dr Jeffrey Goldberger, University of Miami, USA

Trial

Phase 4, LEAF

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 15:19

Cardiovascular disease and diabetes: new guidelines

Presented By

Prof. Emanuele Di Angelantonio; Prof. Nikolaus Marx; Dr Katharina Schuett; Prof. Dirk Müller-Wieland; Prof. Bianca Rocca

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:02

GLP-1 agonists induce weight loss and alleviate headache in idiopathic intracranial hypertension

Presented By

Dr Nik Krajnc, Medical University of Vienna, Austria

Conference

EAN 2023

Type

Peer-reviewed article

7 September 2023 11:00

Diabetes therapy with GLP-1-based drugs does not elevate the risk of IBD

Presented By

Dr Heidi Søgaard Christensen , Aalborg University Hospital, Denmark

Conference

ECCO 2023

Type

Peer-reviewed article

4 May 2023 16:59

HbA1c reduction with GLP-1RA leads to lower risk of CV events in cardiovascular outcome trials

Presented By

Dr Mart Roosimaa , University of Tartu, Estonia

Conference

EASD 2020

Type

News article

14 December 2020 12:35

New guidelines on the prevention of cardiovascular conditions

Presented By

Prof. Roger S. Blumenthal, Johns Hopkins University, USA

Conference

AHA 2019

Type

Peer-reviewed article

26 February 2020 14:36